Hydromer, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HYDI research report →
Companywww.hydromer.com
Hydromer, Inc. invents, develops, patents, licenses, manufactures, and sells hydrophilic polymer-based products and services in the United States and internationally. The company operates in two segments, Polymer Research and Medical Products.
- CEO
- Michael Torti
- IPO
- 1999
- Employees
- 34
- HQ
- Branchburg, NJ, US
Price Chart
Valuation
- Market Cap
- $1.19M
- P/E
- -0.74
- P/S
- 0.32
- P/B
- -8.12
- EV/EBITDA
- -1.99
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 48.85%
- Op Margin
- -45.56%
- Net Margin
- -42.75%
- ROE
- -244.47%
- ROIC
- -200.02%
Growth & Income
- Revenue
- $3.78M · 2.65%
- Net Income
- $-1,614,493 · 40.91%
- EPS
- $-0.34 · 40.35%
- Op Income
- $-1,720,569
- FCF YoY
- -614.58%
Performance & Tape
- 52W High
- $0.45
- 52W Low
- $0.01
- 50D MA
- $0.14
- 200D MA
- $0.17
- Beta
- -0.54
- Avg Volume
- 716
Get TickerSpark's AI analysis on HYDI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HYDI Coverage
We haven't published any research on HYDI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HYDI Report →